Are These 4 Robinhood Penny Shares Able to Take Flight?
Robinhood penny shares have develop into a number of the most trending shares to look at up to now few months. There are just a few the explanation why that is the case. For one, there are a whole bunch of choices in the case of finding penny stocks on Robinhood.
As a result of the time period ‘penny stocks’ itself, applies to any stocks under $5, you may see the choices are aplenty. The second purpose is that Robinhood is without doubt one of the most accessible buying and selling platforms on the market. With zero fee trades and an easy-to-use platform, Robinhood basically democratized buying and selling when it first turned widespread.
Now it’s value noting that the brokerage has its ups and downs. It has been identified to halt buying and selling in occasions of massively heightened quantity, and this has not happy buyers. Nonetheless, we will’t deny that the existence of Robinhood has essentially modified trading penny stocks and blue chips as effectively.
So, due to this, many buyers have turned to Robinhood to buy and sell stocks below $5 due to its $0 fee charges. And whereas many brokerages have adopted swimsuit, Robinhood stays one of the crucial widespread amongst below 35 buyers. So with all of this in thoughts, let’s take take a look at 4 of the perfect penny shares to look at on Robinhood proper now.
4 Robinhood Penny Shares to Watch
- Corbus Prescription drugs Holdings Inc. (NASDAQ: CRBP)
- Meten EdtechX Schooling Group Ltd. (NASDAQ: METX)
- Minerva Neurosciences Inc. (NASDAQ: NERV)
- Akebia Therapeutics Inc. (NASDAQ: AKBA)
1. Corbus Prescription drugs Holdings Inc. (NASDAQ: CRBP)
Corbus Prescription drugs Holdings Inc. is a number one biotech and marijuana stock that has carried out fairly effectively up to now few weeks. It’s possible you’ll be questioning, what does Corbus Prescription drugs Holdings do?
This firm is targeted on the event and commercialization of novel therapeutics that concentrate on autoimmune problems, fibrosis, and most cancers. These endocannabinoid system merchandise embrace its lead candidate lenabasum, which is a cannabinoid receptor kind 2 drugs in Section III trials.
Corbus has plans to current at three upcoming conferences. These embrace the 2021 RBC Capital Markets World Healthcare Convention, Oppenheimer Uncommon & Orphan Illness Summit, and the Jefferies Digital World Healthcare Convention. Forward of those conferences, CRBP inventory is up 24% on Might 14th. It looks like buyers have a bullish sentiment about CRBP forward of its upcoming bulletins.
Simply final month the corporate additionally introduced the completion of enrollment for its Section 2 examine of Lenabasum for treating systemic lupus erythematosus. The examine, sponsored and funded by the Nationwide Institute of Allergy and Infectious Illnesses, will happen over 16 weeks. Sufferers will probably be given both 20 mg twice every day, 20 mg as soon as every day, 5mg twice every day, or placebo.
As you may see, Corbus has lots in its pipeline. This might make CRBP a extra enticing choice to long-term and short-term penny inventory buyers. This penny inventory has skilled many ups and downs in 2021, which illustrates how risky it’s.
With costs transferring incessantly, buyers ought to do not forget that issues can usually get dangerous. However in case you are cautious in the way you make investments, this threat will be mitigated. With this in thoughts, is CRBP in your record of penny shares to look at?
2. Meten EdtechX Schooling Group Ltd. (NASDAQ: METX)
Meten EdtechX Schooling Group Ltd. is a tech penny stock that gives English language coaching companies in China. The corporate supplies its companies in 4 other ways. This consists of common grownup English coaching, abroad coaching companies, on-line English coaching, and junior English coaching. Presently, it operates 105 studying facilities in 28 cities and 15 provinces in China.
The corporate intends on reporting its first-quarter monetary outcomes on Thursday, Might twentieth. This doesn’t imply there aren’t different updates which have come from Meten. The corporate did report on Might twelfth that it has achieved optimistic money circulation in March 2021. This working money circulation was generated due to rising gross billing generated by its offline studying facilities because it has recovered operation after the pandemic.
It intends on persevering with this by closing poorly performing shops and letting go of workers in addition to rising its gross sales by the optimization of its incentive plan. It additionally plans on rising the effectivity of its advertising. Within the first quarter of 2021, Meten noticed a 485% improve in gross billing and a 483% improve in scholar enrollment of its junior English language coaching enterprise. The corporate expects to develop 82% in gross billing this 12 months.
Should you’ve been finding penny stocks to watch lately, you’ll know that many have gotten concerned in blockchain expertise. Whereas Meten is just not a pure play blockchain penny stock, it’s working to become involved. The corporate is planning to make full use of blockchain expertise with its choices. The corporate has positioned a give attention to accelerating technological innovation and digital transformation of on-line training through blockchain.
It could be capable to give college students clear, credible, and tamper-proof digital certificates to mitigate educational dishonesty. This might become broadly utilized in all sorts of training sections. When taking exams, for instance, the corporate might make sure that no dishonest happens utilizing its digital platform. With all of those developments in thoughts, is METX in your penny inventory watchlist?
3. Minerva Neurosciences Inc. (NASDAQ: NERV)
The biotech firm, Minerva Neurosciences Inc., focuses on creating and commercializing central nervous system illness remedy merchandise. Its lead product is roluperidone which is a compound that’s in Section III trials to deal with schizophrenia. It’s engaged on remedies for Parkinson’s as effectively.
On Might twelfth the corporate reported its 2021 monetary outcomes and enterprise updates. Its outcomes for its schizophrenia trial are very optimistic. It’s seeing a steady enchancment in unfavorable signs, steady enchancment in private and social efficiency, and has a positive security profile.
“The outcomes of the open-label extension of the section 3 trial with roluperidone present extra help for the continued growth of this agent, significantly in an setting with a seamless vital unmet medical want for schizophrenia remedies with novel mechanisms of motion.”
Dr. Remy Luthringer, Govt Chairman and CEO of Minerva
For its monetary outcomes, its internet much less fell lots 12 months over 12 months from $12.2 million to $8.8 million. After this promising schizophrenia examine knowledge was launched, the corporate’s inventory value has soared. NERV inventory is up 5.5% on Might 14th, and up about 25% within the final 5 days.
This has positioned a bullish sentiment on Minerva that has triggered its quantity to be about 1.2 million larger than common. Its new encouraging knowledge ought to help a New Drug Software to the FDA following the completion of a bioequivalence examine. With all of this info in thoughts, will you spend money on NERV to your penny inventory watchlist?
4. Akebia Therapeutics Inc. (NASDAQ: AKBA)
Akebia Therapeutics Inc. focuses on the event and commercialization of renal therapeutics. These are in use to deal with sufferers which have a spread of kidney ailments. One in every of its fundamental merchandise is vadadustat, which is an oral remedy in Section III growth to deal with anemia attributable to persistent kidney illness. It additionally has Auryxia which is aferric citrate-based drugs used to manage serum phosphorus ranges in adults with CKD on dialysis.
When Might tenth got here round, Akebia launched its first-quarter 2021 monetary outcomes and highlighted its latest firm milestones. It submitted a New Drug Software or NDA to the U.S. Meals and Drug Administration for Vadadustat throughout this era.
“Akebia is off to an amazing begin in 2021, constructing optimistic momentum with stable execution on strategic priorities that set the stage for an thrilling 12 months. Most significantly, we submitted the vadadustat NDA to the FDA, a big milestone for Akebia and our accomplice, Otsuka Pharmaceutical Co. Ltd.
We’re additionally very proud that the New England Journal of Drugs lately revealed the outcomes from each INNO2VATE and PRO2TECT, the worldwide Section 3 packages for vadadustat.”
The CEO of Akebia, John P. Butler
With regard to its financials, its whole income fell 12 months over 12 months due to decrease collaboration income. That is due to the completion of two of its Section 3 medical packages. For a similar purpose, its R&D bills fell 12 months over 12 months. Its internet loss additionally elevated for comparable causes.
The corporate believes that regardless of the unfavorable impression of COVID-19 on its enterprise, it has favorable odds for the long run. The corporate remains to be being cautious with the pandemic occurring, but it surely states that it might have product income progress in 2021. AKBA inventory has elevated in worth by about 17% since this report was launched.
Does this imply that AKBA will proceed to develop in 2021? That is unsure, however we’ll know extra about the place the corporate stands when its subsequent replace is launched. Will AKBA inventory make your list of penny stocks to look at this month?
Are These Penny Shares on Robinhood Value It?
Discovering the hottest penny stocks on Robinhood is usually a problem for some. Should you don’t know what you’re on the lookout for, it may be simple to get misplaced and find yourself within the crimson. Nonetheless, with a buying and selling training and a dedication to studying as a lot as you may, shopping for and promoting penny shares on Robinhood will be simple.
[Read More] How to Buy Penny Stocks In 2021
As well as, buyers ought to use the instruments at their disposal to determine if sure shares align with their portfolios and investing types. Contemplating all of this, are these Robinhood penny shares value it?